During the occurrence and development of malignant tumors, the production of eotaxin-1/CCL11 16, 17, IL-5, eotaxin-2/CCL24 and RANTES/CCL5 can activate the chemokine receptors CCR3 and CCR1 on eosinophils 18, 19. This evidence concerns the gene CCL11 and cancer.